Kajal Gokal: Loughborough University, England
Dr Gokal is a senior researcher in Behavioral Medicine at the Centre for Lifestyle Medicine and Behavior (CLiMB) in the School of Sport, Exercise and Health Sciences at Loughborough University. Her research focuses on the implementation of behavior change interventions to support the uptake and maintenance of physical activity for both primary and secondary cancer prevention. This involves addressing the barriers to physical activity during and after treatment as well as providing support and the tools to manage and monitor progress. She has a strong interest in how new approaches involving both digital technology and self-managed physical activity can help achieve this goal.
Jianguang Ji: Lund University, Sweden
Dr Jianguang Ji, MD, PhD, is a Senior Lecturer at the Clinical Research Centre (CRC), Center for Primary Health Care Research, Department of Clinical Sciences, Malmö at Lund University. His research has a strong focus on the influence of genetic and environmental factors on cancer incidence and mortality. By using data from nationwide registers and national and regional surveys, the main aim of his research is to shed new light on potential genetic and environmental factors associated with the development of various types of cancer, with a main focus on cancer prevention.
Brigid Lynch: Cancer Council Victoria, Australia
Associate Professor Brigid M. Lynch is Deputy Head of the Cancer Epidemiology Division at Cancer Council Victoria and an Honorary Principal Fellow at the Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne. Her research focuses on how physical activity is associated with cancer risk, biological mechanisms underlying risk, and health outcomes for cancer survivors. Her research interests include applying causal inference methods to help advance the field of physical activity epidemiology. Brigid is a Principal Investigator of the Australian Breakthrough Cancer Study, an ongoing cohort study of over 50,000 Australians investigating the role that genes, lifestyle and environment play in the development of cancer and other diseases.
Noah Peeri: Memorial Sloan-Kettering Cancer Center, USA
Dr Peeri is a Research Scholar at Memorial Sloan-Kettering Cancer Center in the Department of Epidemiology and Biostatistics. He received his Masters in Public Health in Epidemiology from the University of South Florida, and his Doctorate in Epidemiology from the University of North Texas Health Science Center. He has training in advanced epidemiologic methods, as well as nutritional and cancer epidemiology. Much of his research has focused on the intersection of environmental and genetic risk factors and their role in cancer etiology, specifically primary central nervous system tumors. Currently, his research focuses on reducing cancer health disparities across several cancer types.
Hongmei Zeng: Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China
Prof Hongmei Zeng received her PhD degree from Peking University and was a visiting scholar at Yale University and Harvard University. She serves as deputy director of the National Central Cancer Registry, and is a core member of the Chinese National Cancer Registration and Follow-up Program. She has published more than 100 articles on cancer epidemiology, which have been cited more than 30,000 times by researchers. Some of her research has provided a benchmark for Chinese health plans such as “Healthy China 2030 Blueprint” and has been cited by the WHO Health Policy Framework.
Wen Zhang: Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China
Prof Wen Zhang received a PhD in Biochemistry and Molecular Biology in 2011 and is a specialist in cancer biotherapy, Immuno-Oncology, and liquid biopsy. His research focuses on immunotherapy, including the application of oncolytic viruses, the correlation between immunotherapy and tumor microenvironment, and cell therapy. Furthermore, a significant portion of his efforts has been dedicated to the field of liquid biopsy, with a particular emphasis on the clinical implementation of circulating tumor cells. He is an Editorial Board Member for BMC Medicine.
Xiaotao "Rony" Zhang: The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, USA
Dr Xiaotao ‘Rony’ Zhang is an Assistant Professor at the Institute for Translational Epidemiology and Division of Liver Diseases, Department of Medicine with expertise in microbiome, nutritional epidemiology, and cancer epidemiology. Rony earned his medical degree in Preventive Medicine in China. With a growing interest in disease prevention at the level of population health, he emigrated to the US to continue his education and training in Biostatistics and Epidemiology at Tulane University in New Orleans and The University of Texas Health Science Center in Houston. His research and experience are primarily focused on nutrition, the microbiome, liver diseases, and cancer prevention. By merging epidemiologic methods with innovative techniques and bioinformatic/statistical strategies, his current research examines the role of biological and modifiable factors in fatty liver diseases and liver cancer. He hopes to unravel risk factors and mechanisms to inform the development of new preventive interventions and clinical strategies.
